Medifast

OverviewSuggest Edit

Medifast is a leading provider of clinically proven, portion-controlled weight-loss programs. Medifast is on a mission to enrich lives by providing innovative choices for lasting health.When you choose Medifast, you get a powerful product along with the support of an unusually committed company. We are passionate about offering hope to those who want freedom from obesity.

Unlike other companies who manufacture their foods overseas, Medifast makes most of its products in our wholly-owned manufacturing facility just a couple of blocks from our executive offices in Owings Mills, MD. We offer over 70 meal replacement products, including bars, brownies, soups, chili, puddings, and oatmeals.

TypePublic
Founded1980
HQBaltimore, USMap
Websitemedifast1.com
Employee Ratings3More
View Jobs (25)

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2018)420(+6%)
Job Openings25
Revenue (FY, 2018)$501 M(+67%)
Share Price (Nov 2019)$79.8

Medifast Office Locations

Medifast has an office in Baltimore
Baltimore, US (HQ)
100 International Drive 18th Floor
Show all (1)

Medifast Financials and Metrics

Medifast Revenue

Embed Graph
View revenue for all periods
Medifast's revenue was reported to be $501 m in FY, 2018
USD

Revenue (Q3, 2019)

190.1m

Gross profit (Q3, 2019)

142.9m

Gross profit margin (Q3, 2019), %

75.2%

Net income (Q3, 2019)

15.9m

EBIT (Q3, 2019)

20.3m

Market capitalization (12-Nov-2019)

945.0m

Closing stock price (12-Nov-2019)

79.8

Cash (30-Sep-2019)

81.2m
Medifast's current market capitalization is $945 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

356.9m285.3m272.8m274.5m301.6m501.0m

Revenue growth, %

12%(20%)(4%)1%

Cost of goods sold

89.0m76.1m71.5m68.9m73.8m121.1m

Gross profit

267.8m209.2m201.3m205.7m227.8m379.9m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

86.5m86.5m80.9m74.0m73.4m72.2m65.9m72.3m71.1m68.6m70.6m75.7m77.2m98.6m117.3m139.2m165.9m187.1m190.1m

Cost of goods sold

21.6m22.6m20.5m19.1m19.6m19.0m16.8m19.2m17.9m16.4m17.7m18.1m19.0m23.8m28.5m32.0m40.7m46.4m47.1m

Gross profit

64.9m63.9m60.4m54.9m53.8m53.2m49.2m53.2m53.2m52.2m52.9m57.6m58.2m74.8m88.8m107.2m125.1m140.7m142.9m

Gross profit Margin, %

75%74%75%74%73%74%75%74%75%76%75%76%75%76%76%77%75%75%75%
show all
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

36.4m24.5m42.0m52.4m75.1m81.4m

Inventories

18.1m2.9m13.3m18.3m19.3m38.9m

Current Assets

92.0m81.9m88.1m101.3m125.2m145.5m

PP&E

40.3m33.5m29.0m19.8m18.6m19.7m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

48.0m41.4m32.0m27.6m33.4m37.1m39.0m47.3m58.6m57.1m54.0m63.5m70.6m87.0m81.1m82.3m101.8m96.3m81.2m

Inventories

17.5m15.9m17.6m16.2m14.2m12.4m11.8m13.2m11.4m15.0m19.9m18.0m16.0m17.3m26.9m43.8m43.3m48.5m51.9m

Current Assets

106.9m99.8m92.3m79.1m87.6m86.1m84.7m92.1m97.8m103.2m103.6m110.7m115.3m131.1m135.1m151.9m169.3m172.0m158.3m

PP&E

41.1m39.1m37.1m36.0m32.5m31.1m29.5m27.0m20.1m20.1m19.1m18.5m18.8m18.4m18.2m18.8m23.3m25.0m26.2m
show all
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

24.0m13.2m20.1m17.8m27.7m55.8m

Depreciation and Amortization

11.4m8.1m7.1m5.4m4.2m4.4m

Inventories

2.7m(349.0k)2.4m(5.0m)(1.0m)(18.7m)

Accounts Payable

(1.4m)(376.0k)(2.4m)770.0k10.7m16.0m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Net Income

18.7m6.0m11.7m16.5m4.4m10.7m16.2m4.3m7.7m13.7m6.1m13.7m20.4m12.2m26.4m40.1m20.8m42.1m58.0m

Depreciation and Amortization

7.9m2.5m5.1m7.3m3.7m5.4m1.6m3.0m4.2m1.1m2.1m3.2m1.5m2.7m3.5m1.1m2.2m3.4m

Inventories

3.4m2.2m480.0k1.9m14.2m3.3m4.0m92.0k2.0m(1.7m)(1.6m)263.0k2.3m2.9m(6.7m)(23.6m)(4.4m)(9.6m)(13.0m)

Accounts Payable

2.1m(621.0k)(1.6m)310.0k25.5m(596.0k)(1.7m)1.3m(229.0k)1.8m(1.2m)(22.0k)1.8m(3.4m)12.0m21.7m14.7m14.0m15.6m
show all
USDY, 2019

Financial Leverage

1.8 x
Show all financial metrics

Medifast Operating Metrics

FY, 2016

Distribution Centers

2

Facilities

1
Show all operating metrics

Medifast Revenue Breakdown

Embed Graph

Medifast revenue breakdown by business segment: 81.0% from Take Shape For Life, 12.8% from Medifast Direct, 5.7% from MWCC- Franchise and 0.5% from Other

Medifast Online and Social Media Presence

Medifast's Trends

Embed Graph

Medifast News and Updates

December 11, 2018

Medifast, Inc. Announces 56 Percent Increase in Quarterly Dividend

BALTIMORE, Dec. 11, 2018 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven, healthy living products and programs, announced today that its Board of Directors has declared a $0.75 cash dividend to its stockholders. The quarterly cash...
November 14, 2018

Medifast, Inc. Completes $10 Million Stock Repurchase

BALTIMORE, Nov. 14, 2018 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven, healthy living products and programs, today announced it has completed a $10 million stock repurchase. This repurchase was made as part of the Company's...
November 06, 2018

Medifast, Inc. Announces Third Quarter 2018 Financial Results

BALTIMORE, Nov. 6, 2018 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven, healthy living products and programs, today reported financial results for the third quarter ended September 30, 2018. Third Quarter 2018 Highlights: Revenue of ...
September 20, 2018

Short seller Gotham is questioning the quality of Medifast products (MED)

Short seller says shares are worth $30 to $79 Gotham arranged lab tests of Optavia brand weight loss products Lead levels in some products exceed FDA maxmimum intake recommendation Short-selling firm Gotham City Research is questioning the quality and safety of products sold by weight-loss firm M…
September 06, 2018

Global Weight Loss Diet Market 2018 Key Players: Weight Watchers, Jenny Craig, NutriSystem, Medifast, Herbalife, Visalus.

WiseGuyReports.com adds “Weight Loss Diet Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting 2025” reports tits database. Posted via Industry Today. Follow us on Twitter @IndustryToday
September 04, 2018

Weight Loss Diet 2018 Global Market Key Players – Weight Loss Diet, Weight Watchers, Jenny Craig, NutriSystem, Medifast, Herbalife.....

Weight Loss Diet – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025 Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more

Medifast Blogs

July 11, 2018

How to Live Life in the Grey

Typically, when we think of the color grey a dull or uninteresting image comes to our minds. Or perhaps we think of it as the opposite of a lively and... Read More

 Medifast Frequently Asked Questions

  • When was Medifast founded?

    Medifast was founded in 1980.

  • How many employees does Medifast have?

    Medifast has 420 employees.

  • What is Medifast revenue?

    Latest Medifast annual revenue is $501 m.

  • What is Medifast revenue per employee?

    Latest Medifast revenue per employee is $1.2 m.

  • Who are Medifast competitors?

    Competitors of Medifast include The Joint, Partnership Assurance Group and Noom.

  • Where is Medifast headquarters?

    Medifast headquarters is located at 100 International Drive 18th Floor, Baltimore.

  • Where are Medifast offices?

    Medifast has an office in Baltimore.

  • How many offices does Medifast have?

    Medifast has 1 office.